1. Home
  2. STN vs ABVX Comparison

STN vs ABVX Comparison

Compare STN & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stantec Inc

STN

Stantec Inc

HOLD

Current Price

$88.86

Market Cap

10.3B

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$113.41

Market Cap

9.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
STN
ABVX
Founded
1954
2013
Country
Canada
France
Employees
N/A
67
Industry
Military/Government/Technical
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
9.7B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
STN
ABVX
Price
$88.86
$113.41
Analyst Decision
Buy
Buy
Analyst Count
1
13
Target Price
$175.00
$131.31
AVG Volume (30 Days)
212.8K
843.3K
Earning Date
05-13-2026
03-23-2026
Dividend Yield
0.74%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.06
$52.14
Revenue Next Year
$6.61
$4,132.27
P/E Ratio
$28.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$84.08
$5.59
52 Week High
$114.52
$148.83

Technical Indicators

Market Signals
Indicator
STN
ABVX
Relative Strength Index (RSI) 48.97 45.81
Support Level $84.76 $107.55
Resistance Level $96.29 $129.84
Average True Range (ATR) 2.15 5.19
MACD 0.37 -0.69
Stochastic Oscillator 48.52 14.91

Price Performance

Historical Comparison
STN
ABVX

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: